[0001] This Application claims the benefit of priority from U.S. Ser. No. 60/407,863, entitled A Method for Retrospective Birth Dating of Cells” filed Sep. 3, 2002. All patents, patent applications, and references cited in this specification are hereby incorporated by reference, in their entireties.
[0002] The invention provides novel methods for determining the age or birth date of biomolecules, cells, tissues and organs from animals, plants, viruses, as well as organism age.
[0003] Many cells in the body have a set life span. In some organs, cells undergo continuous turnover, and old cells are replaced by new ones. Often, mature or differentiated cells can divide to give rise to more cells of the same type. Yet, differentiated cell types such as neurons are unable to divide. In such cases, new cells are generated by less differentiated stem or progenitor cells. Information about cell turnover is crucial to the understanding of basic biological processes. Many diseases affect the generation of new cells, and information about cell turnover would provide novel insights into the causes and treatments for such diseases.
[0004] Cell turnover has been studied by several methods. One method evaluates cell markers that are selectively expressed in cells undergoing mitosis. The expression of such markers can be used to study cell proliferation for various tissues. Yet, this method provides a limited amount of information, since it only detects cells at the time of cell division. Because many cells die shortly after division, mitosis markers cannot provide an accurate assessment of the number of new cells that are formed in an organ or tissue. Moreover, this method cannot be used to measure the phenotype of new cells generated from stem or progenitor cells.
[0005] Another method involves labeling dividing cells with a stable, inheritable marker. This can be done by administering labeled nucleotides that integrate into the genome of dividing cells. Nucleotides can be labeled with a radioactive isotope (e.g.,
[0006] Yet another method involves injecting retroviruses that have been constructed to express a particular marker. With this approach, only cells that complete a new cell division will take up the retrovirus. Although this method allows accurate determination of cell division, injection of the viral vectors causes trauma to the tissue surrounding the injection site, and cannot be used for human studies. Therefore, there is a need to develop more accurate methods for evaluating cell turnover, which can be used for post-mortem analysis, and for analysis of human organs and tissues.
[0007] The brain and the spinal cord have historically been considered regions devoid of neurogenesis in the periods following embryonic and early postnatal development. However, it has recently been established that new neurons are continuously generated from stem cells residing in the adult mammalian brain (McKay, 1997). Neurogenesis has been shown to occur in the song system and hippocampal formation of song-birds (Macklis), and new neurons have been found in the hippocampal formation and olfactory bulb of rodents (Altman and Das, 1965; Palmer, T. D., et al., (1997)
[0008] Whether neurogenesis takes place in other regions of the adult primate brain remains controversial (Gould, E., et al., (1999)
[0009] Carbon exists in the atmosphere in three isoforms:
[0010] This exponential decrease in atmospheric
[0011] Recent advances in the sensitivity and accuracy of mass-spectrometric techniques (e.g., accelerator mass spectrometry; AMS) have allowed counts for the number of
[0012] In accordance with this invention, AMS-based methods are used to measure the
[0013] In the method of the invention, the delta
[0014] The term biomolecule, for the purpose of this disclosure refers to one or more biomolecules. So, for example, a biomolecule may be a DNA molecule, a collection of DNA molecules, a chromosome, a cell, a whole tissue section, an organism (including an animal, a plant, or a virus). Where the biomolecule comprise more than one molecule type, the birth date is the average birth date of all the biomolecules being analyzed.
[0015] One embodiment of the invention is relates to a method for determining a birth date of a biomolecule comprising. In the method, a carbon containing biomolecule is provided. A delta
[0016] In one aspect of the method, the biomolecule is a whole tissue, such as, for example, a brain section, a liver section, a heart section and the like. In another aspect, the biomolecule is isolated from a tissue. In those aspects, the biomolecule can be an intracellular molecule such as DNA. The biomolecule may comprise a whole animal (e.g., small or unicellular animal), a plant or a virus. In another aspect, the biomolecule may be a purified cell population such as, for example, an isolated neuronal cell population, spleen cell population, liver cell population and the like. The cell population can be further purified by the use of known techniques such as FACS. The biomolecule may be a DNA purified from any of the tissues, cell populations, and organisms listed in this disclosure. In another aspect, the purified cell population may be further purified according to a secondary birth date sorting method before delta
[0017] The delta
[0018] Another aspect of the invention relates to a method of determine the birth date of a biomolecule in a organism population. In the method, a sample of said biomolecule from an organism population is collected and purified away from other carbon containing molecules of the organism population. Then a delta
[0019] In one aspect, the biomolecule may be a tooth enamel from an animal. While any animal may be used, the preferred animal is a mammal such as a human, a horse, a pig, a cow, a rabbit, a dog, a rat and a mouse. A birth date may be calculated by knowledge of when the enamel is generally formed in an animal. For example, in a horse, the enamel of the incisors are generally 6 years younger than the birth date of the animal. Thus, if the enamel shows an age of 10 years, the horse would be about 16 years old. This method can be generally applied to any animal where the enamel date relative to birth date is known.
[0020] Another aspect of the invention relates to a screening method for determining if a candidate agent have an effect on cell proliferation. In the method, a sample tissue is taken from the animal and tested for it's birth date using any of the methods of the invention. Then the animal is administered the' candidate agent. After administration, another sample tissue, similar in type and location is collected from the animal and the tissue's birth date is determined. The two birth dates are compared to determine if cell proliferation has occurred. If cell proliferation has occurred, the birth date of the tissue is expected to decrease (younger) representing new cell proliferation. Any tissue may be tested. Example of tissues include any tissue in this specification and at least, includes neuronal and CNS tissue, liver, spleen, heart, and pancreas.
[0021] Another aspect of the invention relates to a screening method for determining if a treatment has an effect on cell proliferation. In the method, a sample tissue is taken from the animal and tested for it's birth date using any of the methods of the invention. Then the animal is administered a treatment. After the treatment, another sample tissue, similar in type and location is collected from the animal and the tissue's birth date is determined. The two birth dates are compared to determine if cell proliferation has occurred.
[0022] Treatment may encompassed any treatment such as, for example, electroshock, trauma, an induced disorder, a surgical procedure, and the administration of an agent.
[0023] Another aspect of the invention is directed to a method for determining a birth date of a biomolecule. In the method, a biomolecule is provided. An isotope concentration in the biomolecule is determined. The isotope may be any isotope that exhibit uniform changes of concentration with time. Exemplarity isotopes include nitrogen and carbons. A birth date of the biomolecule may be determined by isotope concentration with a calibration isotope concentration chart.
[0024] In any of the method of the invention, the determination of the birth date of a biomolecule may be used to determine the birth date of a cell, a tissue, or an organism comprising the biomolecule. For example, DNA is usually produced during cell birth. The birth date of DNA will reflect the birth date of the cell, and the tissue where the DNA is collected.
[0025]
[0026]
[0027]
[0028]
[0029]
[0030]
[0031] The invention is directed to methods of determining the age of a biomolecule by determining the delta
[0032] As stated above, because DNA is synthesized at a time which is close to the birth of a cell, and because DNA is not synthesized in a nondividing cell, the measurement of the age of a DNA molecule will provide an accurate indication of the age of a cell. Other carbon containing biomolecules that, like DNA, are synthesized at a time close to the birth of a cell but not synthesized during the life of the cell may be used to determine the age of a cell.
[0033] The delta
[0034] In the late 1970's and throughout the ‘80’s a mass spectrometric method for directly detecting
[0035] The method of AMS utilizes a spectrometer that consists of a source, an accelerator and various detectors. The AMS accelerates a beam of carbon ions to very high energies. At high energy the carbon ion beam can be manipulated using large magnets so that the various isotopes (
[0036] Briefly, the DNA is converted to pure carbon in the laboratory. This prepared sample is placed in an evacuated chamber, where it is bombarded with positive cesium ions (Cs
[0037] Delta
[0038] Since AMS was initially developed for the difficult task of geochronology, in which the highest level of the isotope is a function of its natural production, the sensitivity of AMS stretches from parts per billion to parts per quadrillion. Several magnetic and electric sectors are needed to reduce ion counts to low enough rates that the ion identification techniques can operate.
[0039] The efficient throughput, described in the last paragraph, is possible only with graphitic samples. To facilitate this analysis, all biological samples are combusted to CO
[0040] Since AMS came out of the
[0041] AMS measurements are done to 3-5% precision as measured by the standard deviation of 3 or more measurements of the
[0042] In a preferred embodiment of the invention, a date of a biomolecule synthesis (and hence a date of cell birth) may be determined by consulting a
[0043] Delta
[0044] The method of the invention may be applied to biomolecules, cells, tissues, and organs of any cell—including cells from any organism such as animals, plants, and viruses. The organism may be a mammal such as mice, cattle, sheep, goat, pigs, dogs, rats, rabbits, and primates (including human).
[0045] Other Applications Of The Birth Dating Methods Of The Invention:
[0046] The methods of the invention are suitable for determining the age of cells in the central nervous system (CNS). The development of the mammalian central nervous system (CNS) begins in the early stage of fetal development and continues until the post-natal period. The mature mammalian CNS is composed primarily of neuronal cells (neurons), and glial cells (astrocytes and oligodendrocytes).
[0047] The first step in neural development is cell birth, which is the precise temporal and spatial sequence in which stem cells and stem cell progeny (i.e daughter stem cells and progenitor cells) proliferate. Proliferating cells will give rise to neuroblasts, glioblasts and new stem cells.
[0048] The second step is a period of cell type differentiation and migration when undifferentiated progenitor cells differentiate into neuroblasts and gliolblasts which give rise to neurons and glial cells which migrate to their final positions. Cells which are derived from the neural tube give rise to neurons and glia of the CNS, while cells derived from the neural crest give rise to the cells of the peripheral nervous system (PNS).
[0049] The third step in development occurs when cells acquire specific phenotypic qualities, such as the expression of particular neurotransmitters. For example, at this time, neurons extend processes which synapse on their targets. Neurons are generated primarily during the fetal period, while oligodendrocytes and astrocytes are generated during the early post-natal period. By the late post-natal period, the CNS has its full complement of nerve cells.
[0050] The final step of CNS development is selective cell death, wherein the degeneration and death of specific cells, fibers and synaptic connections “fine-tune” the complex circuitry of the nervous system. This “fine-tuning” continues throughout the life of the host. Later in life, selective degeneration due to aging, infection and other unknown etiologies can lead to neurodegenerative diseases.
[0051] Unlike many other cells found in different tissues, the neurons of the adult mammalian CNS have no ability to enter the mitotic cycle and generate new nerve cells. While it is believed that there is a limited and slow turnover of astrocytes (Korr et al., J. Comp. Neurol., 150:169, 1971) and that progenitors for oligodendrocytes are present (Wolsqijk and Noble, Development, 105:386, 1989), the generation of new neurons does not normally occur. Therefore, neurogenesis (the generation of new neurons) is mostly complete early in the postnatal period.
[0052] Because DNA synthesis is completed at the time of cell birth and cell birth occurs at an early stage in life, the DNA in the CNS can serve as a reliable indicator of the age of the cells. Furthermore, the methods of the invention will allow for a more careful examination of cell division in the CNS. The methods of the invention are useful to determine the birth date, and hence the mitotic activity of adult neuronal cells. This technique is especially important given the recent findings in the stem cell field that show that neurogenesis continues into adulthood in mammals. Currently, there are no other method available to determine the birth date (including retrospective dating) or mitotic activity, which are not detrimental to the animal (including human) being studied.
[0053] The birth dating method of the invention may be used to study disorders. One example of a disorder is CNS disorders. Aberrations in normal neurogenesis have been linked to several neurological conditions. Stress has been shown to suppress neurogenesis (Gould, E., et al., (1998)
[0054] Disregulation of neurogenesis has also been linked to neurodegerative diseases, such as Parkinson's disease and Alzheimer's disease (Barzilai, A., and Melamed, E. (2003)
[0055] In one embodiment, the invention is directed to a method to determine the presence of neurogenesis in an organism. The organism may be any living organism including animals, plants, virus. The animal may be any mammal such as humans, horses, pigs, cows, rats, mice and the like. The methods of the invention may be applied to the tissues in said animal to determine an average birth date. The average birth date would allow the determination for the presence or absence of neurogenesis. Neurogenesis may result as part of normal development, as part of a neurological disease including neurodegenerative diseases, as part of a response to injury, or as part of a response to a drug administered to the animal. The methods of the invention may be used to study any condition and disorders where cell or biomolecule turnover is of interest. Furthermore, if the disorders are treated, for example, by inducing cell division or differentiation or by infusion of new cells, this process may be monitored by the methods of the invention.
[0056] Another important use for the methods of the invention is in the area of drug development and treatment development. A need exists for drug screening purposes and for the study of CNS function, dysfunction, and development. The mature human nervous system is composed of billions of cells that are generated during development from a small number of precursors located in the neural tube. Due to the complexity of the mammalian CNS, the study of CNS developmental pathways, as well as alterations that occur in adult mammalian CNS due to dysfunction, has been difficult. The methods of the invention may be used, for example, to monitor cell division in a CNS cell after treatment of a patient with a candidate drug.
[0057] One embodiment of the invention is a method for determining the birth date of a cell or a cell population. A birth date is defined as the date of the last cell division that give rise to the cell in question. Where biomolecules from multiple cells are pooled for analysis, it is understood that birth date refers to the average birth date of all the cells that contributed to the biomolecule sample. A birth date may be expressed as a year and a month. The accuracy of a birth date determination may be +/−5 years or less. In a preferred embodiment, the accuracy of birth dating is +/−3 years or less, such as, for example, +/−2 years or less or +/−1 year or less. In a most preferred embodiment, the accuracy of the birth dating is +/−6 months.
[0058] In one method of the invention, birth dating is determined by isolating a target cell population. The cell population may be any cell population in an organism. In a preferred embodiment, the cell population is a population that exhibits a low rate of cell division in an animal. While the method of the invention is not limited to cells with low cell division activity, the determination of a cell type with a high cell division rate, for example, blood cells is less useful because most blood cell have a birth date of less than one year. An example of a cell population with low cell division activity is neurons.
[0059] The first step in the study of diseases may involve the isolation of a cell population from an organism. Cell populations may be isolated by simple dissection. Alternatively, the cells may be dissociated from a tissue sample. The dissociated cells may be further sorted, or further purified, using known techniques such as fluorescent antibodies against receptors or cell-type specific protein and the use of fluorescence activated cell sorter. Other methods of cell purification include the use of density gradients such as, for example, a percoll gradient. It should be noted that the methods of the invention are not limited to require live cells. Thus, the range of cell purification techniques are not limited to those that preserve the viability of cells.
[0060] After isolation of a cell population, the DNA from the cell population is isolated. Part of the DNA isolation involves purifying the DNA away from all organic molecules (all non DNA carbon sources) from the cell population. Other organic molecules include RNA, proteins, fatty acids, membranes and the like. RNA may be removed from DNA using standard techniques such as, for example, RNase digestion.
[0061] A delta
[0062] The synthesis date of the DNA may be determined by comparing the delta
[0063] Since DNA synthesis begins at about the same time as cell birth, the birth date of the cell population may be determined from the age of the DNA. Furthermore, if the cell type is known and the life cycle of the cell type in an animal is known, the age of the animal may be determined. For example, the perkingi cells and cerebellum cells have birth dates around the time of birth, liver cells turn divide approximately every three months and many blood cells undergo division weekly.
[0064] The method of the invention may be use to calculate the birth date of any DNA, tooth enamel, cell, or organism with any birth date. In one embodiment, the birth date of the organism is 1963 or later. In another embodiment, the method of the invention is used to calculate a birth date that is after 1964 or later. In a more preferred embodiment, the methods of the invention is used to determine the birth dates from 1965 or later.
[0065] Another embodiment of the invention is directed to a method for determining the birth date of a teeth enamel. In the method, a sample of tooth enamel is collected from an animal and purified away from other carbon containing molecules. Other carbon containing molecules include the other parts of the teeth such as the dentin and the pulp. A delta
[0066] Screening Therapeutics
[0067] The method of the invention may be used to screen agents for the treatment of disorders. The term “agent” refers to something that may influence a biological condition. Often the term will be synonymous with “stimulus” or “stimuli” or “manipulation.” Agents may be materials, radiation (including all manner of electromagnetic and particle radiation), forces (including mechanical, electrical, magnetic, and nuclear), fields, and the like. Examples of materials that may be used as agents include organic and inorganic chemical compounds, biological materials such as nucleic acids, carbohydrates, proteins and peptides, lipids, and mixtures thereof. Other specific examples of agents include non-ambient temperature, non-ambient pressure, acoustic energy, electromagnetic radiation of all frequencies, the lack of a particular material (e.g., the lack of oxygen as in ischemia), etc. The term agent also refers to growth factors involved in neural development. These growth factors includes, but are not restricted to, NGF, NT-3, NT4/5, IGF-1, estrogen, PDGF, bFGF, IGF-1 and 2, NT-3, CNTF, retinoic acid, IL-6, and LIF.
[0068] In Parkinson's disease, a loss of 60% of substantia nigra cells results in the manifestations of clinical symptoms including bradykinesia and tremors. Current therapies are directed at replacing the deficient neurotransmitter, dopamine, or maintaining its presence by blocking its metabolism. By injection of various candidate agents (potential therapeutics), including neuronal cells, a treatment for Parkinson's disease may be explored.
[0069] For example, a candidate agent, dopaminergic cells (neural stem cells, primary cells from the basal ganglia, limbic system, substantia nigra, hypothalamus, the medulla cortex or other cells lines of neural or adrenal origin (such as PC 12)) or dopamine may be administered to a patient suffering from Parkinson's disease. By monitoring average birth date in the substantia nigra before and after the administration, the researcher can determine if neurogenesis has occurred in response to the administration. That is, if neurogenesis has occurred, the average age of the cells in the substantia nigra should drop, to reflect a younger population of cells. The method of the invention, by directly measuring cell division as evident by novel DNA synthesis, is also suitable for determining if an agent can elicit neurogenesis through an indirect, pleotrophic, effect (e.g., by secondary messengers etc).
[0070] This method can be applied to multiple disease paradigms, for example, Alzheimer's disease. Briefly, the average birth date of the basal forebrain is determined. Then a candidate agent is administered to the patient. After administration, the average age of the basal forebrain is determined again to determine if the agent has induced neurogenesis in the basal forebrain.
[0071] While two specific examples, Parkinson's disease and Alzheimer's disease have been discussed above, the method of the invention is suitable for the screen of any agent for the treatment of any disease in a patient which is in some way associated with cell division. The cells assayed by the methods of the invention may be any type of cell.
[0072] Neuronal cells may be analyzed after their isolation from a tissue. As shown in the Example section, neuronal cells may be purified or enriched by flourescent activated cell sorting or other cell sorting techniques. After a cell population is enriched for neuronal cells, the birth date of the cells may be determined by the methods of the invention.
[0073] One advantage of the method of the invention is that it does not rely on live cells. In fact, the methods of the invention is equally applicable to dead cells. Because of this, the methods of the invention may be applied to dead tissue for scientific or forensic purposes. Another advantage of the methods of the invention is that it is applicable to all cells, regardless of their origin, as long as the cells have a biomolecule that can be analyzed. So for example, vegetable cells may be analyzed with the same accuracy as animal cells. Furthermore, more than one type of biomolecules may be analyzed by isolating the molecule and determining a delta
[0074] Another technique that can be used to further refine the age distribution of cells or nuclei includes dating cells (including neurons) based on their level of a cell age indicator.
[0075] One cell age indicator is cell lipofuscin. All cells accumulate a product called lipofuscin with time. The exact molecular composition of this pigment is not fully characterized. However, lipofuschin has a yellow and green autofluorescecent property. This property can be induced using light of 400 to 600 nm to excite the lipofuschin and measuring autofluorescence at 400-640. We can take advantage of the fluorescent properties of lipofuscin to by flow cytomtery isolate subpopulations that have varying levels of lipofuscin, and determine the age of subpopulations with the above described
[0076] Another cell age indicator is histone acetylation. Histone acetylation may be measured by many methods. Two of these methods involves directly adding a florescently tagged antibody to neuronal nuclei that has been extracted and purified from a cell (discussed in another section of this disclosure). The second method involves extracting histones from from NeuN+sorted neurons. The histones extracted are then labeled with an anti-histone fluorescent-conjugated antibody (such as Alexa Fluor 546, Zenon One kit from Molecular Probes). Briefly, histone extraction involves extracting histones with 0.2M H
[0077] A third indicator of cell age is DNA oxidation. DNA oxidation is assessed by looking at oxo8dg levels. Oxo8dg levels have been shown to increase in an age-related manner in all tissues of rodents (Hamilton et al., 2001). Oxo8dg can be directly detected by avidin and its analogues, and represents an additional method for age sorting nuclei. Again, analysis would be by way of FACS sorting of fluorescent-labelled avidin bound oxo8dg (Struthers et al., 1998).
[0078] In each case, cells can be sorted (by FACS if needed) by the cell age indicator into different subpopulations. Each subpopulations may be subjected to a
[0079] For AMS analysis of extracted DNA to be successful and accurate, three aspects are preferred: 1) there needs to be a high yield of DNA; 2) the DNA needs to be as pure as possible; and 3) radioactive or carbon contamination should be eliminated or minimized. Mass spectrometric analysis of human cerebellar DNA has revealed that between 23 and 30% of the total mass of DNA is comprised of carbon. To optimize measurement accuracy, approximately 200 μg or more DNA was extracted from each sample for measurement.
[0080] Different DNA extraction protocols were investigated for their purity and yield of DNA. Two techniques were established which give either a high yield of DNA (phenol extraction method from Sambrook et al., (1989)
[0081] It is noted that any DNA extraction procedure will work for the method of the invention so long as the final DNA extraced is clean of all carbon contining containments. One method of DNA extraction is provided as an example. Whole tissue can be homogenized in a tissue homogenizer and subjected to RNase treatment. After RNase treatment, the DNA is extracted with Phenol/chloroform/isoamyl alcohol to remove non-nucleic acid components. The DNA of the aqueous phase of the extracted preparation may be precipitated by ethanol and 0.3 molar (final concentration) sodium acetate. The precipitated pellet may be washed with 70% ethanol and allowed to dry. The DNA is then resuspended in clean H
[0082] Various types of tissue were collected, such as brain tissue (cerebellum, cortex, hippocampus, and, in particular, dentate gyrus, lateral ventricle, and olfactory bulb) and other tissues, including muscle, liver, bowel, heart, and blood. Teeth were collected from horses and humans. Whole blood was collected, representing the newest source of
[0083] Experiments on whole tissue DNA extractions were conducted with horse and human tissues, and showed excellent results. Analysis was performed for whole tissue, DNA from specific brain and body regions, and tooth enamel. The delta
[0084] DNA was also extracted from various regions in the horse and human brain and body, including the cerebellum (a site expected to have no neurogenesis), cortex (a proposed site of adult neurogenesis), the lateral ventricle and the hippocampus (sites shown to be highly neurogenic), and muscle, liver, bowel, and blood (sites shown to have high rates of cell turnover). DNA from the cerebellum was determined to be very old (
[0085] As expected, the regions with high cell turnover rates, i.e. muscle, liver, bowel and blood DNA, were showed
[0086] Enamel from horse and human also show good correlation with age (
[0087] Additional experiments were performed to further study the differences in
[0088] Fluorescently labelled nuclei were visualized using a fluorescent microscope, and the presence of NeuN-labeled nuclei confirmed. See
[0089] The cell and nuclei purification described above was performed on fresh pig cells and frozen human cells. The positive results and the successful isolation of neuronal nuclei indicate that show that it is possible to analyze a variety of healthy and diseased brain material stored as frozen material in pathology and forensic centers around the world.
[0090] Whilst a small aliquot of the extracted nuclei were used for microscopic analysis, the bulk of the material was prepared for analysis and sorting using fluorescence-activated cell sorting (FACS). Nuclei were labeled with NeuN, as described above, as well as with a DNA stain, such as propidium iodide (PI). PI labeling allowed single nuclei to be sorted from doublets, triplets, etc. (
[0091] Whole cells were also separated on Percoll gradients (
[0092] Once a neuron-specific population of nuclei was collected, the DNA was extracted, cleaned, dried and resuspended in H
[0093] All DNA samples were swiped for radioactive contamination prior to analysis. Once cleared, samples were prepared for processing. Samples were dehydrated from 1 ml to 200 μl, combusted to CO
[0094] Other studies were performed for dating tooth enamel and wood. In one approach, tooth enamel was carefully chipped away to separate it from the underlying dentin, which undergoes continual cell turnover. Another protocol involved cutting away the crown of the tooth and subjecting the tooth to harsh chemical treatments that facilitate the removal of the dentin (Wieser, A., et al., (2001)
[0095] Using the AMS analysis of the invention, enamel from a 19 year old horse tooth was determined to be 14 years old, and enamel from a 6 year old horse was determined to be contemporary (
[0096] Data received from
[0097] In accordance with this invention, data was collected to prepare a bomb-spike curve for Sweden, using tree rings from Swedish Pine. This project was initiated to ensure an accurate measurement of
[0098] Altman, J., and Das, G. D. Autoradiographic and histological evidence of postnatal hippocampal neurogenesis in rats (1965) J Comp Neurol 124(3):319-35.
[0099] Barnea, A., and Nottebohm, F. Seasonal recruitment of hippocampal neurons in adult free-ranging black-capped chickadees (1994) Proc. Natl. Acad. Sci. 91:11217-11221).
[0100] Barzilai, A., and Melamed, E. (2003) Molecular mechanisms of selective dopaminergic neuronal death in Parkinson's disease.
[0101] Bernier, P. J., Bédard, A., Vinet, J., Lévesque, M., and Parent, A. Newly generated neurons in the amygdala and adjoining cortex of adult primates (2002) PNAS 99(17):11464-11469.
[0102] Czeh, B., Michaelis, T., Watanabe, T., Frahm, J., de Biurrun, G., van Kampen, M., Bartolomucci, A, and Fuchs, E. (2001) Stress-induced changes in cerebral metabolites, hippocampal volume, and cell proliferation are prevented by antidepressant treatment with tianeptine.
[0103] Dingley, K. H., Sánchez, E., Vogel, J. S., and Haack, K. W. (2003) DNA isolation and sample preparation for quantitation of adduct levels by Accelerator Mass Spectrometry.
[0104] Eriksson, P. S., Perfilieva, E., Björk-Eriksson, T., Alborn, A-M., Nordborg, C., Peterson, D. A., and Gage, F. H. (1998) Neurogensis in the adult human hippocampus.
[0105] Gould, E., Reeves, A. J., Fallah, M., Tanapat, P., Gross, C. G., and Fuchs, E. Hippocampal neurogenesis in adult Old World primates. (1999)
[0106] Gould, E., Reeves, A. J., Graziano, M. S., and Gross, C. G. (1999) Neurogenesis in the neocortex of adult primates.
[0107] Gould, E., Tanapat, P., McEwen, B. S., Flugge, G., and Fuchs, E. (1998) Proliferation of granule cell precursors in the dentate gyrus of adult monkeys is diminished by stress.
[0108] Hamilton, M. L., Remmen, H. V., Drake, J. A., Guo, Z. M., Kewitt, K., Walter, C. A., and Richardson, A. Does oxidasive damage to DNA increase with age? (2001) PNAS 98(18):10469-10474.
[0109] Johansson, C. B., Momma, S., Clarke, D. L., Risling, M., Lendahl, U., and Fris'n, J. (1999) Identification of a neural stem cell in the adult mammalian central nervous system.
[0110] Koketsu, D., Mikami, A., Miyamoto, Y., and Hisatsune, T. Nonrenewal of neurons in the cerebral neocortex of adult Macaque monkeys (2003) J Neurosci 23(3):937-942.
[0111] Levin, I. (1992) In:
[0112] Levin, I., and B. Kromer,
[0113] Levin, I., Kromer, B., Schoch-Fischer, H., (1985) 25 years of trophosperic
[0114] Lewis, R. The neurobiology of rehabilitation (2003) The Scientist, 17(13):22-24.
[0115] Lovell, M. A., Robertson, J. D., Buchholz, B., Xie, C., and Markesby, W. R. Use of bomb pulse carbon-14 to age senile plaques and neurofibrillary tangles in Alzheimer's diseas (2002) Neurobiology of Aging 23:179-186.
[0116] McKay, R. Stem cells in the central nervous system (1997) Science 276:66-71.
[0117] Mok, H. Y. I., Druffel, E. R. M., and Rampone, W. M. Chronology of cholelithiasis (1986) New Eng J Med 314(17):1075-1077.
[0118] Nydal, R., and Lövseth, K. Tracing bomb
[0119] Nydal, R., and Lövseth, K. 1997 Carbon-14 measurements in atmospheric CO
[0120] Palmer, T. D., Takahashi, J., and Gage, F. H. (1997) The adult rat hippocampus contains primordial neural stem cells.
[0121] Parent, J. M. (2003) Injury-induced neurogenesis in the adult mammalian brain.
[0122] Rakic, P. (2002) Neurogenesis in adult primate neocortex: an evaluation of the evidence.
[0123] Sambrook, J., Fritsch, E. F., and Maniatis, T. (1989)
[0124] Santarelli, L., Saxe, M., Gross, C., Surget, A., Battaglia, F., Dulawa, S., Weisstaub, N., Lee, J., Duman, R., Arancio, O., Belzung, C., and Hen, R. (2003) Requirement of hippocampal neurogenesis for the behavioural effects of antidepressants.
[0125] Serra, I., Avola, R., Condorelli, D. F., Surrentino, S., Renis, M., Kamiyama, M., Hashim, G. A., and Giuffrida, A. M. Acetylation and phosphorylation of histones and nonhistone chromosomal proteins in neuronal and glial nuclei purified from cerebral hemispheres of developing rat brain (1986) J Neurochem 46:1881-1887.
[0126] Spalding, K. L., Tan, M. M. L., Hendry, I. A., and Harvey, A. R. Anterograde transport and trophic actions of BDNF and NT-4/5 in the developing rat visual system (2002) MCN 19:485-500.
[0127] Struthers, L., Patel, R., Clark, J., and Thomas, S. Direct detection of 8-oxodeoxyguanosine and 8-oxoguanine by avidin and its analogues (1998) Anayltical Biochem 255:20-31.
[0128] Tatebayashi, Y., Lee, M. H., Li, L., Iqbal, K., and Grundke-Iqbal, I. (2003) The dentate gyrus neurogenesis: a therapeutic target for Alzeimer's disease.
[0129] Wieser, A., EI. Faramawy, N., and Meckbach, R. (2001) Dependencies of the radiation sensitivity of human tooth enamel in EPR dosimetry.
[0130] Zhao, M., Momma, S., Delfani, K., Carlen, M., Cassidy, R., Johansson, C., Brismar, H., Shupliakov, O., Frisen, J., and Janson, (2003) A. M. Evidence for neurogenesis in the adult mammalian substantia nigra.